Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 22 May 2026 for Andersen Group Inc., €73k.
Filing timeline
BuySaleRobert Gunderson V Jr.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+21.5%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +65.6%Entry US$38.31 · Close 22 Oct 2026 US$63.45
- +158.0%Entry US$24.59 · Close 22 Oct 2026 US$63.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Gunderson V Jr.: trading record in brief
This profile gathers the share dealings of Robert Gunderson V Jr. across 4 companies, led by Innoviva, Inc., Theravance Biopharma, Inc. and Vitae Pharmaceuticals, Inc. In total, 22 filings cover trades dated from 22 April 2008 to 20 May 2026.
No open-market sale appears; the market trades are 2 purchases worth €245k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 14 share grants and 1 option exercise. Since January 2026: 1 purchase and no sales on the market.
On 22 May 2026 came the latest disclosure, an open-market purchase for €73k in Andersen Group Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Gunderson V Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
2,367 shares@ US$35.8229.8% of flowClass A Common StockSEC:0001193125-26-236973:0
Canonical exit: 18 Aug 2026 (T+90)
12,633 shares@ US$16.0070.2% of flowClass A Common StockSEC:0001193125-25-328741:0
Canonical exit: 18 Mar 2026 (T+90)
9,828 shares0Ordinary SharesSEC:0001179110-21-004698:0
6,635 shares0Ordinary SharesSEC:0001179110-20-005297:0
8,385 shares0Ordinary SharesSEC:0001179110-19-005455:0
8,186 shares0Ordinary SharesSEC:0001179110-18-006189:0
6,000 shares0Ordinary SharesSEC:0001179110-17-007539:0
11,002 shares@ US$21.0041.0% of flowCommon StockSEC:0001104659-16-151947:0
15,830 shares@ US$21.0059.0% of flowCommon StockSEC:0001104659-16-151947:1
6,000 shares0Ordinary SharesSEC:0001179110-16-023945:0
6,000 shares0Ordinary SharesSEC:0001179110-15-006598:0
6,548 sharesCommon StockSEC:0001209191-14-060546:0
4,454 sharesCommon StockSEC:0001209191-14-060546:1
6,000 shares0Common StockSEC:0001179110-14-009240:0
25,806 shares@ US$9.69Common StockSEC:0001179110-14-007021:0
6,000 shares0Common StockSEC:0001179110-13-007287:0
6,000 shares0Common StockSEC:0001179110-12-008608:0
6,000 shares0Common StockSEC:0001179110-11-007006:0
768 shares0Common StockSEC:0001179110-10-018172:0
6,000 shares0Common StockSEC:0001179110-10-007511:0
6,000 shares0Common StockSEC:0001179110-09-006752:0
6,000 shares0Common StockSEC:0001179110-08-008185:0
22 of 22 declarations
